SARS-CoV-2 - Chloroquine - Therapeutic Candidates

SARS-CoV-2 - Chloroquine - Therapeutic Candidates


Chloroquine (also called chloroquinine) is an antimalarial drug of the 4-aminoquinoline family that has been widely marketed as salts (sulphate or phosphate). Chloroquine, quinine and hydroxychloroquine are the most widely used treatments against malaria, both preventive and curative. This molecule has also shown efficacy in the treatment of certain autoimmune diseases such as lupus and rheumatoid diseases such as rheumatoid arthritis. Chloroquine also shows antiviral effects, although for the time being these have mainly been observed in vitro.
With the COVID-19 pandemic caused by the SARS-CoV-2 virus, chloroquine has attracted interest, along with other molecules, as a potential antiviral. Chloroquine is believed to be effective in vitro in inhibiting the replication of SARS-CoV-2. Chloroquine appears to be responsible for raising the pH of the lysosomes of cells targeted by the virus. However, the efficacy of chloroquine as a treatment in patients infected with CoV-2-SARS has yet to be proven but many studies are ongoing. 

Ergebnis Ihrer Suche : 178 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD
  • Unconjugated 31
  • [3H] 1
  • Biochemicals 134
  • Inhibitor/Antagonist/Agonist 41
  • Protein/peptide 2
  • Radiochemicals 1
  • Assay 3
FILTER ANWENDEN
REINITIALISIEREN


Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
B4874-1ml
 10mM(in1mLH2O) 
T9287-100mg
 100mg 
T9287-200mg
 200mg 
T9287-500mg
 500mg 
HY-W031727-100mg
 100mg 
279799-50mg
 50mg 
TRC-H916905-25MG
 25mg 
279799-10mg
 10mg 
279799-100mg
 100mg 
452085-1mg
 1mg 
452085-5mg
 5mg 
331-21357-2
 50mg 
279388-10g
 10g 
TRC-N597800-100MG
 100mg 
279388-25g
 25g